De Trizio Ignazio, Komninou Maria Angeliki, Ernst Jutta, Schüpbach Reto, Bartussek Jan, Brandi Giovanna
Institute for Intensive Care Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Centre of Clinical Nursing Science, University Hospital Zurich, Zurich, Switzerland.
BMC Neurol. 2025 Jan 15;25(1):22. doi: 10.1186/s12883-025-04025-7.
Delirium is a common complication in patients at the intensive care unit (ICU) and is associated with prolonged ICU-stay and hospitalization and with increased morbidity. The impact of ICU-delirium on long-term survival is not clearly understood.
This retrospective single center observational study was conducted at the Institute of Intensive Care Medicine at the University Hospital Zurich, Switzerland. All adult ICU-survivors over a four-year period were screened for eligibility. ICU-delirium was defined based on the Intensive Care Delirium Screening Checklist (ICDSC), together with the coded diagnosis F05 in the International Classification of Diseases (ICD-2019). ICU-survivors who developed delirium during their ICU stay (group D) were compared with ICU-survivors who did not (group ND). Survival was evaluated according to data from hospital electronic health records up to four years from ICU-discharge. The survival analysis was reported using Kaplan-Meier curves and absolute risk differences (ARD). A multivariable logistic regression model was fitted with long-term survival at four years after ICU-discharge as outcome of interest, including several clinical conditions and interventions associated with long-term survival for ICU patients. For subgroup analysis, ICU-survivors were grouped based on age at the time of admission (45-54, 55-64, ≥ 65 years), and on relevant clinical conditions.
A total of 9'604 patients fulfilled the inclusion criteria, of them 22.6% (n = 2'171) developed ICU-delirium. Overall, patients in the group D had a significantly lower probability of survival than patients in the group ND (p < 0.0001, ARD = 11.8%). In the multivariable analysis, ICU-delirium was confirmed as independently associated with long-term survival. After grouping for age categories, patients between 55 and 64 years of age in the group D were less likely to survive than patients in the group ND at every time point analyzed, up to four years after ICU discharge (p < 0.001, ARD = 7.3%). This difference was even more significant in the comparison between patients over 65 years (p < 0.0001, ARD 11.1%). No significant difference was observed in the other age groups.
In the study population, ICU-delirium was independently associated with a reduced long-term survival. Patients who developed ICU-delirium had a reduced survival up to four years after ICU discharge and this association was particularly evident in patients above 55 years of age.
谵妄是重症监护病房(ICU)患者常见的并发症,与ICU住院时间延长、住院时间延长及发病率增加有关。ICU谵妄对长期生存的影响尚不清楚。
本回顾性单中心观察性研究在瑞士苏黎世大学医院重症医学研究所进行。对四年期间所有成年ICU幸存者进行资格筛查。ICU谵妄根据重症监护谵妄筛查检查表(ICDSC)以及国际疾病分类(ICD-2019)中的编码诊断F05进行定义。将在ICU住院期间发生谵妄的ICU幸存者(D组)与未发生谵妄的ICU幸存者(ND组)进行比较。根据医院电子健康记录的数据评估从ICU出院后长达四年的生存率。生存分析采用Kaplan-Meier曲线和绝对风险差异(ARD)报告。采用多变量逻辑回归模型,以ICU出院后四年的长期生存作为感兴趣的结果,包括与ICU患者长期生存相关的几种临床情况和干预措施。对于亚组分析,ICU幸存者根据入院时的年龄(45-54岁、55-64岁、≥65岁)以及相关临床情况进行分组。
共有9604例患者符合纳入标准,其中22.6%(n = 2171)发生了ICU谵妄。总体而言,D组患者的生存概率显著低于ND组患者(p < 0.0001,ARD = 11.8%)。在多变量分析中,ICU谵妄被确认为与长期生存独立相关。按年龄类别分组后,D组中55至64岁的患者在分析的每个时间点,直至ICU出院后四年,其生存可能性均低于ND组患者(p < 0.001,ARD = 7.3%)。在65岁以上患者的比较中,这种差异更为显著(p < 0.0001,ARD = 11.1%)。在其他年龄组中未观察到显著差异。
在研究人群中,ICU谵妄与长期生存降低独立相关。发生ICU谵妄的患者在ICU出院后长达四年的时间里生存率降低,这种关联在55岁以上的患者中尤为明显。